The Association between Hyperuricemia and High Blood Pressure in Different Age Groups among Police Officers Coming for Medical Treatment and Health Check-up
Article Sidebar
Main Article Content
Abstract
Background: Hypertension has been reported as the most commoncause of cardiovascular disease and increased trends globally. Hyperuricemia has been reported as the associated factor of gout. Many studiesshowed a positive relationship between uric acid and blood pressure with some studies being inconclusive. We examined the associationbetween hyperuricemia and high blood pressure in different age groupsamong police officers coming for medical treatment and health check-ups.
Objectives: This study aimed to investigate the association between hyperuricemia and high blood pressure in different age groups among police officers coming for medical treatment and health check-ups.
Methods: An observational study, analytic cross-sectional study, retrospective chart review (1 January 2016 - 31 December 2018) was performed.Multiple linear regression, and multiple logistic regression were used for analysis.
Results: A total of 1,307 participants above 30 years of age were divided into three age groups: 30-39 years, 40-59 years, and above 60 years. After adjustment for sex, BMI, cholesterol, HbA1C, and eGFR, higher uric acid was significantly associated with higher SBP (30-39 and 40-59 age groups) and higher DBP (40-59 age groups). Hyperuricemia was also a risk factor for high blood pressure in the 40-59 age group.
Conclusions: Hyperuricemia was associated with high blood pressure in the 40-59 age group. Additionally, higher uric acid level was significantly associated with higher SBP and DBP in the middle-aged group
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The content and information in articles published in the PCFM journal are solely the opinions and responsibilities of the authors. The journal's editorial board does not necessarily agree with or share any responsibility for them.
All articles, information, content, images, etc., published in the PCFM journal are the copyright of the PCFM journal. If any individual or organization wishes to reproduce, distribute, or use any part or the entirety of the content, they must obtain written permission from the PCFM journal beforehand.
References
Fuchs FD, Whelton PK. High blood pressure and cardiovascular disease. Hypertension. 2020;75:285-92.
NCD Risk Factor Collaboration (NCD-RisC). World- wide trends in hypertension prevalence and pro- gress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representa- tive studies with 104 million participants. Lancet. 2021;398(10304):957–80.
Thai Hypertension Society. 2019 Thai guidelines on the treatment of hypertension. Chiang Mai: Trick Think publisher; 2019. (in Thai)
Burden of Disease Research Program Thailand. Thailand burden of diseases attributable to risk fac- tors 2014. Nonthaburi: International Health Policy Program; 2018.
สมาคมรูมาติสซั่มแห่งประเทศไทย. แนวทางเวชปฏิบัติการ ดูแลรักษาโรคเกาท์ (Guideline for Management of Gout) พ.ศ. 2555. กรุงเทพฯ: สมาคมรูมาติสซั่มแห่งประเทศไทย; 2555.
Butler F, Alghubayshi A, Roman Y. The Epidemiolo- gy and Genetics of Hyperuricemia and Gout across Major Racial Groups: A Literature Review and Popu- lation Genetics Secondary Database Analysis. J Pers Med. 2021;11:231.
Uaratanawong S, Suraamornkul S, Angkeaw S, Uara- tanawong R. Prevalence of hyperuricemia in Bang- kok population. Clin Rheumatol. 2011;30:887-93.
Kanbay M, Segal M, Afsar B, Kang DH, RodriguezIturbe B, Johnson RJ. The role of uric acid in the pathogenesis of human cardiovascular disease. Heart. 2013;99:759-66.
Sung K-C, Byrne CD, Ryu S, Lee J-Y, Lee SH, Kim J-Y, et al. Baseline and change in uric acid concentra- tion over time are associated with incident hyper- tension in large Korean cohort. Am J Hypertens. 2017;30:42–50.
Kuwabara M, Hisatome I, Niwa K, Hara S, RoncalJimenez CA, Bjornstad P, et al. Uric acid is a strong risk marker for developing hypertension from pre- hypertension: a 5-year Japanese Cohort Study. Hy- pertension. 2018;71:78-86.
Cao Z, Cheng Y, Li S, Yang H, Sun L, Gao Y, et al. Mediation of the effect of serum uric acid on the risk of developing hypertension: a populationbased cohort study. J Transl Med. 2019;17:202.
Cheng YB, Li Y. Hyperuricemia: Does It Matter for the Progression from Prehypertension to Hyperten- sion? Hypertension. 2018;71:66-7.
Lanaspa MA, Andres-Hernando A, Kuwabara M. Uric acid and hypertension. Hypertens Res. 2020;43:832-4.
Piani F, Cicero AFG, Borghi C. Uric acid and hyper- tension: Prognostic role and guide for treatment. J Clin Med. 2021;10:448.
Lee SJ, Oh BK, Sung K-C. Uric acid and cardiometa- bolic diseases. Clin Hypertens. 2020;26:13.
Forman JP, Choi H, Curhan GC. Plasma uric acid level and risk for incident hypertension among men. J Am Soc Nephrol.2007;18:287–92.
Sedaghat S, Pazoki R, Uitterlinden AG, Hofman A, Stricker BH, Ikram MA, et al. Association of uric acid genetic risk score with blood pressure: the Rotter- dam study. Hypertension. 2014;64:1061-6.
Lee JJ, Ahn J, Hwang J, Han SW, Lee KN, Kim JB, et al. Relationship between uric acid and blood pressure in different age groups. Clin Hypertens. 2015;21:14.
Cheng W, Wen S, Wang Y, Qian Z, Tan Y, Li H, Hou Y, et al. The association between serum uric acid and blood pressure in different age groups in a healthy Chinese cohort. Medicine (Baltimore). 2017;96(50): e8953.
Ohyama Y, Imai K, Obokata M, Araki M, Sumiyoshi H, Koitabashi N, et al. Impact of uric acid on in- cident hypertension: Sex-specific analysis in dif- ferent age groups. Int J Cardiol Hypertens. 2019; 2(100009):100009.
Niu X, Chen J, Wang J, Li J, Zeng D, Wang S, et al. Association between the uric acid and hyper- tension in community-based Chinese population: stratified analysis based on body mass index and age. J Thromb Thrombolysis. 2021;51:1113-9.
Aunchalee K. The relationship between uric acid with other laboratory in Phang-nga policeman. Reg11MedJ. 2018;32:1345-56.
Jameson JL, Fauci AS, Kasper DL, Hauser SL, Longo DL, Loscalzo J. Harrison’s principles of internal medicine, twentieth edition (vol.1 & vol.2). 20th ed. Columbus, OH: McGraw-Hill Education; 2018.
Lee SW, Kim HC, Nam C, Lee H-Y, Ahn SV, Oh YA, et al. Age-differential association between serum uric acid and incident hypertension. Hypertens Res [Internet]. 2019 [cited Year Mont Date];42:428–37. Available from: http://dx.doi.org/10.1038/s41440-
-0168-4
